Creative Diagnostics Launches Custom Virus Production Service

Creative Diagnostics has recently introduced the research community with customized virus production services. - August 26, 2022 - Creative Diagnostics

Creative Diagnostics Launches New Livestock Infectious Diseases Antigens

Creative Diagnostics announced the launch of more than 20 antigens for the development of veterinary infectious diseases diagnostics and vaccines. - August 26, 2022 - Creative Diagnostics

CABRI Announces Call for Proposals on Specialized Pro-Resolving Mediator Analytical Methods

The Cayman Biomedical Research Institute (CABRI) is offering research grants in amounts up to $100,000 to support essential research on specialized pro-resolving mediator (SPM) analytical methods. - August 26, 2022 - Cayman Chemical Company

Deadline Extended: CABRI Announces Undergraduate Fellowships and Scholarship Program

The Cayman Biomedical Research Institute (CABRI) is accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted from August 22 until September 18, 2022. - August 26, 2022 - Cayman Chemical Company

Jillian Altizer Joins AeroGo as Human Resources Manager

Jillian Altizer Joins AeroGo as Human Resources Manager

Jillian Altizer Joins AeroGo as Human Resources Manager. - August 25, 2022 - AeroGo, Inc.

Triad Control Systems, LLC, a Full-Service Automation Company, Acquires Certain Assets of CJ Automation & Controls, LLC

Triad Control Systems, LLC, a Full-Service Automation Company, Acquires Certain Assets of CJ Automation & Controls, LLC

Triad Control Systems, LLC (TCS) announced today that it has entered into an agreement to purchase certain assets and contracts of CJ Automation and Controls, LLC (CJAC). The transaction is scheduled to close on or about September 1, 2022. This acquisition will enhance TCS’s capabilities to... - August 25, 2022 - Triad Control Services

NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies

NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies

NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced it has received a $1.8 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National... - August 24, 2022 - NanoCellect Biomedical

Pharma CI Conference Returns Next Month: Meet Hundreds of Industry Leaders at the Top Event for 15+ Years

Pharma CI Conference Returns Next Month: Meet Hundreds of Industry Leaders at the Top Event for 15+ Years

Ready, set, engage! The Pharma CI USA Conference & Exhibition is back in person and ready to deliver the industry-leading experience that has made Pharma CI the gold standard event for more than fifteen years. The much-anticipated return happens this September 21-22 at the Newark Liberty... - August 18, 2022 - Pharma CI Conference

Gilgal Medical Supplies Launches Wholesale Medical Supplies Distribution

Gilgal Medical steps into a huge void where hospitals, nursing homes and pharmacies are not getting their supplies on time. - August 17, 2022 - Gilgal Medical Supplies

Coalition to Cure CHD2 Announces Two Recipients of Its 2022 Early-Stage Investigator Research Grant

Two $30,000 seed research grants were awarded to investigators studying CHD2-related neurodevelopmental disorders. - August 15, 2022 - Coalition to Cure CHD2

Reliance Medical Centers Looks Ahead to Being the Area’s Best Neighbor with Tampa "Welcome to the Neighborhood" Farmer’s Market Event

Reliance Medical Centers Looks Ahead to Being the Area’s Best Neighbor with Tampa "Welcome to the Neighborhood" Farmer’s Market Event

Reliance Medical Centers, a popular Central Florida Primary Care Doctor’s Office is celebrating its new Tampa Lowry Park location with free Farmer's Market for senior adults on Tuesday, August 16, 2022. - August 12, 2022 - Reliance Medical Centers

VMRD Begins Manufacturing Key Reagent for Detection of CWD by RT-QuIC

VMRD Begins Manufacturing Key Reagent for Detection of CWD by RT-QuIC

Veterinary Medical Research & Development (VMRD), Pullman, WA, has partnered with CWD Evolution, Fort Collins, CO, to provide state-of-the-art diagnostic reagents for detection of the abnormal prion associated with Chronic Wasting Disease (CWD). The control of CWD requires identification of... - August 09, 2022 - VMRD, Inc.

Hospice Home Care Expands to Cover All of Los Angeles County

Hospice Home Care Expands to Cover All of Los Angeles County

Every city in Los Angeles Country will be serviced by Hospice Home Care. The department that has been created will allow doctors, nurses, volunteers and other hospice care professionals to service thousands of patients in the Los Angeles area. - August 08, 2022 - Hospice Home Care

Peptineo, LLC Selected by EPA to Provide EPA Nationwide Coverage for Point of Care (POC) COVID-19 Testing

The Environmental Protection Agency (EPA), Cincinnati Acquisition Division (CAD), has awarded Peptineo LLC, an emerging aerospace, health services, and defense solutions company, a three-year Blanket Purchase Agreement (BPA) to support a comprehensive COVID-19 testing program in support of the... - August 07, 2022 - Peptineo

Hemanext Announces Publication of Hypoxic Blood Storage Study in Blood Advances

Research shows that hypoxic storage preserves faster oxygen unloading from red blood cells compared to standard conditions. - August 05, 2022 - Hemanext

Tim Wintz and Jarett Greenside Promoted to Senior Vice Presidents of Radiology for NY Imaging Specialists

Tim Wintz and Jarett Greenside Promoted to Senior Vice Presidents of Radiology for NY Imaging Specialists

NY Imaging Specialists announced today the appointments of Tim Wintz and Jarett Greenside to Senior Vice Presidents of Radiology. - August 02, 2022 - New York Imaging Specialists

Meridian Diagnostics Helps Healthcare Practices Make Better Decisions

Meridian Diagnostics Helps Healthcare Practices Make Better Decisions

Meridian Diagnostics is a clinical diagnostic reference laboratory based in Colorado and offers services to clinics, laboratories, employers and healthcare practices nationwide. Their aim is to assist healthcare providers with making informed decisions for their patients. Meridian realizes you have many options for laboratory services, but their 18-24 hour turn-around-time on all results from UTI, toxicology, blood, and various respiratory pathogens makes them the lab of choice for providers. - July 26, 2022 - Meridian Diagnostics

Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research

Creative Diagnostics announced the launch of several Monkeypox Virus Antibodies and Antigens for the detection of Monkeypox viruses. - July 22, 2022 - Creative Diagnostics

Creative Diagnostics Introduces New Cell-Based ELISA Services

Creative Diagnostics is offering comprehensive services for Cell-based ELISA that can measure the reduction of viral antigens in infected cells using anti-virus antibodies or compounds. - July 22, 2022 - Creative Diagnostics

Heartland Pharmacy Creates New Collaborative Care Program

Heartland Pharmacy Creates New Collaborative Care Program

Heartland Pharmacy is launching a new senior care program to promote collaborative care for advanced physical wellness. - July 21, 2022 - Heartland Pharmacy

International Panel of Experts Provides Guidance on Key Questions in Risk Assessment of PFAS Chemicals

International Panel of Experts Provides Guidance on Key Questions in Risk Assessment of PFAS Chemicals

A new peer-reviewed report by a panel of scientists sheds new light on regulation and management of per- and polyfluoroalkyl substances (PFAS). SciPinion, which objectively engages the global scientific community to analyze the toughest scientific topics, today announced the publication of an... - July 19, 2022 - SciPinion

Mako Medical CEO Chad Price Announces Company Expansion in Virginia with the Alliance

Mako Medical CEO Chad Price Announces Company Expansion in Virginia with the Alliance

Chad Price, CEO of Raleigh-based Mako Medical and Mako Medical Laboratories, announced the company is expanding its service throughout the state of Virginia by adding a new member to the laboratory Alliance. - July 18, 2022 - Mako Medical Laboratories

Chad Price, CEO of Raleigh-Based Mako Medical & Mako Medical Laboratories Launches a New Monkeypox Test

Chad Price, CEO of Raleigh-Based Mako Medical & Mako Medical Laboratories Launches a New Monkeypox Test

Chad Price, CEO of Mako Medical, recently announced his team has developed a monkeypox test. - July 18, 2022 - Mako Medical Laboratories

PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program

PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program

PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Spring 2022 program. The graduates successfully completed the 10-week PharmaU program, which culminated with the Showcase Event held June 8-10 in Boston. The Showcase Event brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - July 12, 2022 - PharmStars

Pharmacy Stars’ New Sterile Compounding Quality Peer Network Aims to Fill the Role Once Held by the Now Discontinued CriticalPoint Peer Network

Pharmacy Stars’ New Sterile Compounding Quality Peer Network Aims to Fill the Role Once Held by the Now Discontinued CriticalPoint Peer Network

Pharmacy Stars to launch the Sterile Compounding Quality Peer Network with the goal of filling the vacated role of CriticalPoint’s Peer Network, an online forum designed to support 503A entities, their regulators, and their certifiers. The CriticalPoint Peer Network has been discontinued as of June 30, 2022, according to the CriticalPoint website. - July 11, 2022 - Pharmacy Stars, LLC

ReproTech, LLC Welcomes New President & CEO, William Braun

ReproTech, LLC Welcomes New President & CEO, William Braun

ReproTech, LLC, the industry leader in human reproductive tissue cryogenic storage, is pleased to announce that William J. Braun has been selected as ReproTech’s new President and Chief Executive Officer. Braun assumed the role on April 4, 2022, and will be based in ReproTech’s Coconut Creek, FL location. - July 09, 2022 - ReproTech, LLC

Team Arnav Foundation to Hold 3rd Annual Event

Team Arnav Foundation to Hold 3rd Annual Event

Public announcement telling folks to participate in a local event whose proceeds help eradicate pediatric osteosarcoma. - July 09, 2022 - Team Arnav Foundation

River Valley Relief Names Ryan Kenaga President

River Valley Relief (RVR), a family-owned medical cannabis cultivator located in Fort Smith, Arkansas makes some organizational changes and names new President. - July 08, 2022 - River Valley Relief

Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results

Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results

Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. - July 08, 2022 - Global Cancer Technology

Terrain Health Partners with Novel Biotech Company Microgenesis to Offer Breakthrough Solutions for Infertility

Terrain Health, an international precision healthcare organization partners with novel biotechnology, science research company Microgenesis, to offer a natural and effective solution to restore fertility potential by identifying root cause of infertility issues, now shown to be linked to the health of the gut microbiome. - July 06, 2022 - Terrain Health Inc.

Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa

Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing and storage technology, today announced the appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East and Africa (EMEA). In his role,... - July 05, 2022 - Hemanext

Don't Let Joint Pain Hold You Back

Adventist Health Simi Valley is Ventura County’s first Robotic Center of Excellence and provides the community with the latest joint-replacement techniques resulting in less pain, shorter hospital stays and quicker recoveries. - July 02, 2022 - Adventist Health

NF Sports Releases New "Immune Defense(TM)" Drink Mix

Nutrition Supplement Company Aims to Combat Weakened Immune Systems by Helping to Limit the Spread of Viruses at the Cellular Level. - June 30, 2022 - NF Sports

Foundation Supporting Indigenous Students to Return a Half-Million Dollars to a Catholic Organization

Foundation Supporting Indigenous Students to Return a Half-Million Dollars to a Catholic Organization

The Verna J. Kirkness Education Foundation Board Chair, Tony Williams, plans to announce the Board’s decision to return the $500,000 endowment to the Sisters of Saint Anne and terminate the 4.5-year-long relationship. In his announcement, Tony Williams will explain his Board’s decision... - June 24, 2022 - Verna J. Kirkness Foundation

iTech Offers 60-Day Free Trial on expEDIum Medical Billing® Product

iTech, a leading Healthcare IT Solutions vendor specializing in delivering a secure, affordable, and comprehensive cloud-based Medical Billing & Practice Management Software, offers a 60-day free trial on their expEDIum Medical Billing® product. - June 24, 2022 - expEDIum

PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator

PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator

PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars

Defined Bioscience Announces Formation of Scientific Advisory Board

Defined Bioscience, a life science tools company pioneering the development of next generation ingredients for cell culture, today announced the formation of its scientific advisory board (SAB). The SAB is comprised of a distinguished group of academic and industry experts who will advise the... - June 15, 2022 - Defined Bioscience Inc.

GENINVO Launches Its Latest Offering - Innovation as a Service

GENINVO, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Innovation as a Service. GENINVO has recognized various challenges the pharmaceutical industry faces, especially in the wake of the pandemic. The need to expedite clinical... - June 12, 2022 - GenInvo, Inc.

Creative Diagnostics Launches Measles Virus Antigens for the Detection of Antibodies

Creative Diagnostics announced the release of new measles virus antigens suitable for both IgM and IgG detection. - June 11, 2022 - Creative Diagnostics

Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety

Creative Diagnostics introduced CC50/IC50 testing services with a high level of detection sensitivity and accuracy. - June 11, 2022 - Creative Diagnostics

HealthWare Systems Expands Services

HealthWare Systems meets evolving client needs with healthcare automation solutions, RPA, and services divisions – CredentialingOne & EligibilityAdvocates. - June 10, 2022 - HealthWare Systems

PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort

PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort

PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars

Isaac Health Launches Affordable, Convenient Specialist Memory Clinic Services at Home

Isaac Health Launches Affordable, Convenient Specialist Memory Clinic Services at Home

Isaac Health is a national provider of dementia care via a virtual platform from the safety of your home. They diagnose, treat, manage, and coordinate care for you in collaboration with your physician, loved ones, and/or senior living community - June 04, 2022 - Isaac Health

Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI

Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI

Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022 - ALS Therapy Development Institute

Period Tracking App, Femometer, Launches Discount and Offers in Celebration of 10 Million Users

Reproductive, period, and pregnancy tracking app, Femometer, is celebrating a milestone of 10 million users. Femometer is offering more than half-off the Prime Membership option, as well as select products purchased through the app. The celebratory discount will be available to users from the 1st of June to 8th of June. - May 31, 2022 - Lollipop Technology Hangzhou Ltd. Co.

Scientific Reports Publishes Data Demonstrating VR Platform Produces Peak Experiences, Ego Attenuation & Connectedness Comparable to Moderate Dose Psychedelics

Scientific Reports Publishes Data Demonstrating VR Platform Produces Peak Experiences, Ego Attenuation & Connectedness Comparable to Moderate Dose Psychedelics

aNUma, Inc., a digital therapeutics company building virtual reality programs to address the global mental health crisis, today, announced that Scientific Reports has published research demonstrating technology like that behind aNUma’s VR platform can deliver peak experiences, ego attenuation, and connectedness comparable to psychedelics. This study, written by Dr. David Glowacki and colleagues, is the first of its kind to be published in a leading peer-reviewed journal. - May 30, 2022 - aNUma

Creative Diagnostics Launches Antibody-Dependent Enhancement Assay Services

Creative Diagnostics recently introduces comprehensive services for antibody-dependent enhancement (ADE) assay. - May 26, 2022 - Creative Diagnostics

Creative Diagnostics Announces Antigens for Epstein-Barr Virus Antibody Tests

Creative Diagnostics recently launched recombinant antigens p18 and p23 (viral capsid antigens, VCA), p54 and p138 (early antigens, EA) and EBNA1 (nuclear antigen, EBNA). - May 26, 2022 - Creative Diagnostics

Paradigm Immunotherapeutics to Present at LABEST 2022 Incubator Showcase

Paradigm Immunotherapeutics to Present at LABEST 2022 Incubator Showcase

Dr. Neil Bodie, CEO of Paradigm, will discuss Paradigm’s groundbreaking biological, virtual mask in his presentation, “A Breakthrough in SARS CoV-2/COVID Prophylactics.” Dr. Neil Bodie, CEO of Paradigm Immunotherapeutics (“Paradigm”), will present at the Los Angeles... - May 25, 2022 - Paradigm Immunotherapeutics

ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit

ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit

The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover pre-clinical research exploring potential new therapeutic drug-like molecules and targets for ALS, as well as translational research analyzing patient data to identify new ALS biomarkers, drug targets, and patient populations. - May 25, 2022 - ALS Therapy Development Institute

Press Releases 451 - 500 of 8,719